Skip to main content
. 2023 Mar 25;2023(3):omad022. doi: 10.1093/omcr/omad022

Figure 1.

Figure 1

CD4 counts (cells/mm3) and VLs (copies/ml of plasma) evolution: A considerable drop in CD4 cell count and increase in VLs during the non-adherence time interval with the patient’s initial regimen (TDF + 3TC + EFV) was observed. Based on the findings, the initial regimen was switched to ABC + DTG + ATV/r, followed by improved immunologic status and virologic outcomes, as illustrated.